Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: 36.94M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: November 14, 2022 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast February 13, 2023 November 14, 2022 - / - - / - August 10, 2022 - / - - / - June 21, 2022 - / -0.1657- / -February 14, 2022 -0.1147 / -0.1037- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 11, 2022 1.150 1.150 1.150
1.150
2.54K 3.60% Aug 9, 2022 1.110 1.140 1.140
1.110
2.06K 0.91% Aug 8, 2022 1.100 1.100 1.100
1.100
3.64K 0% Aug 4, 2022 1.100 1.060 1.100
1.060
0.25K 5.77% Aug 2, 2022 1.040 1.050 1.050
1.040
6.33K -0.95% Jul 29, 2022 1.050 1.070 1.070
1.040
5.51K -1.87% Jul 28, 2022 1.070 1.070 1.070
1.070
0.12K 0% Jul 27, 2022 1.070 1.070 1.070
1.070
0.40K 0% Jul 26, 2022 1.070 1.100 1.100
1.070
0.90K -3.6% Jul 22, 2022 1.110 1.110 1.110
1.110
0.20K -0.89% view more
More profiles and info about the company News
Acasti Pharma GAAP EPS of -$0.11 seekingalpha.com Nov 14, 2022 8:15 pm Acasti says court dismissed challenge to Grace Therapeutics acquisition seekingalpha.com Sep 30, 2022 9:45 pm Acasti begins dosing of GTX-102 for neurodegenerative disorder; appoints chief commercial officer seekingalpha.com Sep 13, 2022 9:27 pm Acasti Pharma reports GAAP EPS of $0.27 for FY2022 seekingalpha.com Jun 21, 2022 8:10 pm Acasti gets patents related to brain hemorrhage drug GTX-104, pain therapy GTX-101 seekingalpha.com Jun 14, 2022 9:04 pm Acasti says pharmacokinetic trial for lead asset met all study goals seekingalpha.com May 18, 2022 8:55 pm
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares finance.yahoo.com Sep 1, 2020 4:23 pm Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint marketwatch.com Sep 1, 2020 2:31 pm Acasti Pharma GAAP EPS of -$0.10 seekingalpha.com Aug 11, 2022 7:08 pm Acasti Pharma GAAP EPS of -$0.09 misses by $0.01 seekingalpha.com Feb 14, 2022 8:00 pm Acasti Pharma jumps 21% on new Outperform rating at Oppenheimer with PT of $6 seekingalpha.com Dec 22, 2021 8:16 pm Acasti says candidate for subarachnoid hemorrhage met main goals in pivotal PK study seekingalpha.com Dec 2, 2021 8:40 pm Acasti Pharma EPS beats by $0.60 seekingalpha.com Nov 10, 2021 8:20 pm Acasti Pharma Q2 Earnings Preview seekingalpha.com Nov 10, 2021 2:07 am Acasti Pharma initiates pharmacokinetic bridging study for lead candidate GTX-104 seekingalpha.com Sep 27, 2021 8:42 pm Acasti Pharma regains compliance with Nasdaq's listing rule seekingalpha.com Sep 22, 2021 10:09 pm Innate Pharma, Adagio top weekly healthcare gainers, Acasti Pharma, Forte Biosciences trail seekingalpha.com Sep 4, 2021 10:37 am Acasti Pharma to effect 8-1 reverse stock split, closes Grace Therapeutics merger seekingalpha.com Aug 27, 2021 9:03 pm Acasti Pharma reports FQ1 results seekingalpha.com Aug 12, 2021 7:42 pm Acasti updates on acquisition of Grace Therapeutics and announces fiscal 2021 results seekingalpha.com Jun 22, 2021 7:56 pm Talk about Acasti Pharma Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?
